Bortenat Bortezomib Injection

Bortenat Bortezomib Injection Specification

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Salt Composition
Bortezomib 2mg

Dosage Form
Injection

Feature
Lyophilized for Injection, Preservative Free

Ingredients
Bortezomib

Application
Anticancer Therapy

Physical Color/Texture
Lyophilized powder

Storage Instructions
Store below 25C, protect from light

Shelf Life
24 months

About Bortenat Bortezomib Injection

Bortenat Bortezomib Injection :-

Bortezomib generic Valcade is used treating relapsed multiple myeloma and mantle cell lymphoma.BorteNat (Bortezomib) interferes with the growth of some cancer cells and keeps them from spreading in your body.

BorteNat (Bortezomib) is sometimes given after other cancer medications have been tried without successful treatment.

BorteNat (Bortezomib generic Velcade ):-

BorteNat (Bortezomib) can cause harm to an unborn baby. Do not receive BorteNat (Bortezomib) without telling your doctor if you are pregnant. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment.BorteNat (Bortezomib) can lower blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Your liver function may also need to be tested. Do not miss any scheduled appointments.

Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection.

Avoid becoming dehydrated if you have any vomiting or diarrhea. Symptoms of dehydration include dizziness, dry mouth, fainting, or hot and dry skin. Talk with your doctor about how best to keep yourself hydrated.

BorteNat (Bortezomib) can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert.

Before receiving BorteNat (Bortezomib)

You should not use BorteNat (Bortezomib) if you are allergic to bortezomib, mannitol, or boron.

If you have certain conditions, you may need a dose adjustment or special tests to safely receive this medication. Before you receive BorteNat (Bortezomib), tell your doctor if you have:

diabetes;
liver disease;
if you are on dialysis;
a bleeding or blood clotting disorder;
a low level of platelets or white or red blood cells;
heart disease, congestive heart failure;
herpes or a history of shingles;
high or low blood pressure; or
nerve problems such as burning, numbness, burning, pain, or tingly feeling

Targeted Cancer Treatment

Bortenat Bortezomib Injection provides precise anticancer therapy for patients diagnosed with multiple myeloma and mantle cell lymphoma. By inhibiting proteasomes within cancer cells, it disrupts cellular processes crucial to cancer growth. Its effectiveness has been established in clinical settings and is trusted by healthcare professionals across India.

Safe Administration and Handling

This medication is supplied in a sterile glass vial as a lyophilized powder and must be reconstituted with sterile 0.9% sodium chloride before intravenous or subcutaneous administration. To ensure patient safety, Bortenat should only be used under medical supervision, adhering to dosage and reconstitution protocols provided by healthcare providers.

Key Benefits of Bortenat

Bortenat offers significant benefits for eligible patients, including improved response rates and progression-free survival. Its preservative-free formulation reduces the risk of adverse reactions, and precise dosing helps mitigate side effects while maximizing clinical outcomes. Its robust packaging and long shelf life facilitate safe distribution and storage.

FAQs of Bortenat Bortezomib Injection:

Q: How should Bortenat Bortezomib Injection be prepared for administration?

A: Bortenat must be reconstituted by dissolving the lyophilized powder in sterile 0.9% sodium chloride solution before intravenous or subcutaneous injection, following the instructions provided by the healthcare professional.

Q: What indications is Bortenat Bortezomib Injection prescribed for?

A: This product is prescribed for the treatment of multiple myeloma and mantle cell lymphoma, as determined and supervised by a qualified physician.

Q: When should Bortenat be administered?

A: Bortenat should be administered as per the schedule outlined by a healthcare provider, commonly during chemotherapy cycles specific to the patients therapeutic needs and regimen.

Q: Where should Bortenat Bortezomib Injection be stored?

A: The vials should be stored below 25C, protected from light, in a secure location, ensuring adherence to storage guidelines for maximal potency throughout the 24-month shelf life.

Q: What is the process for administering Bortenat Bortezomib Injection?

A: After reconstitution, the injection is given either intravenously or subcutaneously by a healthcare provider in a clinical setting, ensuring accurate dosing and patient monitoring.

Q: How does Bortenat benefit patients undergoing cancer therapy?

A: Bortenat delivers targeted anticancer action, improving treatment outcomes for multiple myeloma and mantle cell lymphoma while reducing potential side effects through its preservative-free formulation.

Q: Who can supply or distribute Bortenat in India?

A: Licensed dealers, distributors, exporters, suppliers, traders, and wholesalers in India can provide Bortenat, ensuring it reaches hospitals and pharmacies for prescription use.

Get Latest Price